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As part of the introduction of the New Zealand Public Health and Disabilities Act in 2000, the 
introduction of the Population Based Funding Formula led to a change in the flow of funds for 
transfer patients. Prior to the PBFF, for the years 2000-2003, healthcare events were 
contracted on a fee-for-service basis and thus were borne by the DHB of treatment. From 2003 
onwards, the cost of transfer patients followed the transfer back to their DHB of domicile. This 
study replicates and extends work done by Shin (2013) in assessing the impacts of this change 
in funding flows on the level of transfer and patient health outcomes. I use OLS and logistic 
modelling to empirically assess these effects and draw conclusions as to the effectiveness of 
the policy change and any potential efficiencies that are gained. I find evidence of a focus in 
the probability of transfers after the change in funding, where the overall probability of 
transfer decreases and the probability of transfer to tertiary DHBs increases. Additionally, 
patient outcomes demonstrate a concentration effect whereby after the policy is 
implemented, the pool of transfers is less diluted by low severity patient transfers and thus 
displays poorer health outcomes on average for the transfer group. The concentration of 
health outcomes suggests that the transfer decision is being considered more carefully now 
that costs are aligned to the DHB of domicile. A novel addition to this research is the analysis 
of regional DHB pairs. The analysis of five secondary-to-tertiary transfer flows provides insight 
into the necessity of a decentralised healthcare system in New Zealand and is mostly consistent 
with the analysis at the national level. Overall, the introduction of Inter-District Flow transfer 
funding has increased the efficiency of the transfer mechanism and enabled a more 
streamlined redistribution of funds to tertiary providers. This is an important finding because 
it reinforces the necessity of the transfer mechanism, specialist providers and local provision 
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